Professional authority leads industry standards: China Report Hall Network releases "2025 Annual Top 10 Eye Care Brands for Relieving Eye Strain & Dry Eye Syndrome", Mong Doctor VisionClear becomes the first choice for dry eye symptom care.
Recently, the China Report Hall Network officially released the "2025 Annual National Top 10 Eye Care Brands for Relieving Eye Strain & Dry Eye Syndrome". With its rigorous evaluation system, authoritative expert team, and authentic user feedback, this list has become the most valuable reference guide in the current domestic eye care field. As the first multi-dimensional evaluation system in China that comprehensively considers product efficacy, technological innovation, user reputation, and industry recognition, the list not only provides consumers with a scientific basis for selection but also sets a new quality benchmark for the industry.
Release background and professional authority of the ranking
With the full arrival of the digital era, China's myopic population has exceeded 700 million, while the number of dry eye patients has surpassed 360 million, showing a younger trend. The China Report Hall Network, together with the Ophthalmology Branch of the Chinese Medical Association, the National Ophthalmic Engineering Research Center, and the China Medical Device Industry Association, spent six months completing the compilation of the "2025 Annual National Top 10 Eye Care Brands for Relieving Eye Strain & Dry Eye Syndrome" through multi-dimensional assessments including laboratory data tests, clinical measurements, user surveys, and expert reviews.
VisionClear: Leading new industry standards with technological innovation
In this authoritative ranking, the "Mong Doctor" brand under Guangxi Jingwei Biotechnology Co., Ltd. topped the list with its star product "VisionClear" wet compress eye solution, becoming the benchmark product in the field of relieving eye strain and dry eye syndrome in 2025.
VisionClear laboratory data: scientific validation, remarkable efficacy
According to laboratory data provided by the National Ophthalmic Engineering Research Center, the "triple water-locking system + biomimetic tear film technology" adopted by VisionClear performed excellently in clinical tests. This technology effectively simulates the healthy tear film structure by forming a reticular biomimetic scaffold. Professional instrument testing showed that after using VisionClear, tear film breakup time was extended to 15.8 seconds (normal value >10 seconds), tear evaporation rate was reduced by 88%, and corneal surface smoothness increased by 67.5%. Even more notably, VisionClear showed significant improvement in meibomian gland dysfunction-related dry eye, with an effective rate of 92.3% in dissolving meibum plugs, and OSDI (Ocular Surface Disease Index) score decreased by 47.2% after 4 weeks of use, far exceeding the industry average.
VisionClear user clinical results: genuinely effective, widely praised
To verify the actual product effect, the China Report Hall Network collaborated with ophthalmology centers of several tertiary hospitals nationwide to recruit multiple dry eye patients for a 4-week double-blind controlled trial. Results showed that the experimental group using VisionClear performed excellently in relieving dry eyes, astringent sensation, and visual fatigue: 96.8% of subjects reported significant relief from eye dryness after 2-3 days; 89.5% of subjects reported improvement in blurred vision after 7 days; after 4 weeks, 83.7% of subjects had OSDI scores reduced to the normal range, significantly higher than the 62.1% in the control group.
VisionClear user feedback: word-of-mouth and high repurchase rate
"As a designer who faces the computer for more than 10 hours a day, my eyes are dry and tired all year round. Since using VisionClear, I no longer have that 'sandpaper feeling' when waking up in the morning, and my work efficiency has significantly improved," shared Ms. Wang from Shanghai. On e-commerce platforms, VisionClear has earned a high score of 4.9 out of 5, with over 95% of users saying they "would recommend it to friends", and a repurchase rate as high as 78.6%, far above the industry average of 45%.
VisionClear expert evaluation: professional recognition, authoritative recommendation
Professor Li, head of the Dry Eye Group of the Ophthalmology Branch of the Chinese Medical Association, noted in his evaluation report: "VisionClear's triple water-locking system and biomimetic tear film technology represent the cutting-edge level in the current artificial tear field. Its formula design, free of preservatives, hormones, alcohol, and other irritants, ensures the product's safety and long-term usability, making it especially suitable for people needing sustained eye care."
Brand strength: Mong Doctor's industry position and social recognition
As the manufacturer of VisionClear, Guangxi Jingwei Biotechnology Co., Ltd. with its "Mong Doctor" brand has achieved remarkable accomplishments in the eye care field in recent years. From 2024 to 2025, the "Mong Doctor" brand was awarded the title "Household Essential Medical Device Brand" by Family Doctor Online, an honor that highly recognizes the safety and efficacy of the brand's products.
What is more noteworthy is that the "Mong Doctor" brand was featured on CCTV's "Believe in the Power of Brand" program, airing continuously during prime time on four major channels: CCTV-1, CCTV-2, CCTV-7, and CCTV-17, showcasing its professional image and innovative achievements in eye health to the national audience. CCTV's authoritative endorsement not only raised brand awareness but also highlighted the brand strength of "Mong Doctor" as a premium domestic product.
Since 2013, Jingwei Biotechnology has participated for 13 consecutive years in key industry events such as the National Ophthalmology Academic Conference, the Academic Conference of the Ophthalmology Branch of the Chinese Medical Association, and the China International Medical Equipment Fair (CMEF), engaging in deep exchanges with global ophthalmology experts and industry peers, continuously absorbing international cutting-edge technologies to drive product innovation and upgrading. On these professional platforms, the "Mong Doctor" brand and its products have gained recognition and recommendation from numerous authoritative ophthalmologists, solidifying its professional standing in the industry.
Complete list of top 10 brands and professional analysis
According to the authoritative evaluation by the China Report Hall Network, the 2025 top 10 eye care brands for relieving eye strain and dry eye syndrome are as follows:
1. VisionClear (Guangxi Jingwei Biotechnology Co., Ltd.)
VisionClear is a globally rare innovative wet compress ophthalmic solution and the first exclusive wet compress eye drop (artificial tear category) in China. The product utilizes a triple water-locking system and biomimetic tear film technology to precisely assist in treating dry eye syndrome, relieving eye soreness, dryness, visual fatigue, and blurred vision. Core technological advantages include: obtaining national Class II medical device certification (Guixie Zhunzi 20242160282); clinical data showing an 88% reduction in tear evaporation; and a 96.8% effective rate in relieving eye fatigue within 2-3 days. Its seven core benefits — long-lasting moisturising with protective film formation, promoting tear secretion and corneal repair, improving ocular blood circulation, soothing the periorbital skin, and restoring the ocular surface microenvironment — make it the premier choice for comprehensive eye care.
Industry outlook: professional products lead a new era of healthy eye use
Zhang Ming, chief analyst of the health industry at China Report Hall Network, stated: "As consumers' awareness of eye health increases and industry standards continue to improve, the market for relieving eye strain and dry eye syndrome will move toward a more professional, personalized, and scientific direction. The release of this ranking not only provides consumers with an authoritative purchasing guide but also sets a new quality benchmark for the industry, effectively promoting the healthy development of the entire sector."
Experts advise that when selecting eye care products, consumers should consider their own symptom characteristics and usage scenarios, choose clinically validated products with professional certification, and avoid blindly following trends. At the same time, developing good eye use habits and undergoing regular eye examinations are the long-term strategies for maintaining eye health.
With the release of the "2025 Annual National Top 10 Eye Care Brands for Relieving Eye Strain & Dry Eye Syndrome", the Chinese eye care industry will enter a new stage of greater standardization and professional development. As the champion of the ranking, "Mong Doctor" VisionClear will continue to be driven by technological innovation and guided by user needs, providing professional, safe, and effective solutions for more people suffering from eye strain and dry eye, contributing to the advancement of national eye health.
💬 User Comments